Navigation Links
Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Dose Escalation Trial with Tovaxin for Multiple Sclerosis

) and relapsing-remitting MS (RR-MS) patients. A total of 100 patients will receive Tovaxin, while 50 will receive placebo. The study is designed as a two-arm, 52-week, parallel-group study, whereby patients will be given five subcutaneous injections at 0, 4, 8, 12 and 24 weeks. The analyses will be performed at the end of the 52-week study to assess the safety and efficacy of Tovaxin. The primary efficacy variable is the cumulative number of gadolinium-enhancing lesions on T1-weighted MRI scans summed over the Week 28, 36, 44, and 52 MRIs. The secondary efficacy variables are the cumulative number of new gadolinium-enhancing lesions at Weeks 28-52, the change in T2-weighted lesion volume, and the annualized relapse rate. As of March 19, 2007, Opexa reported that more than 110 patients have been enrolled in the TERMS clinical trial and the Company expects enrollment to be complete by mid 2007.

All patients who complete the trial will be eligible to participate in an optional one-year extension study, in which they will receive Tovaxin under an open-label protocol. The open-label study is being planned under a different protocol that will be submitted to the FDA.

The TERMS study is being conducted at 36 U.S. sites to evaluate the safety and effectiveness of Tovaxin It is registered on the U.S. National Institutes of Health-sponsored website, www.clinicaltrials.gov, where pharmaceutical companies are required to register trials for medicines that will treat serious or life-threatening diseases or conditions. For more information, visit the TERMS website at www.tovaxin.com.

About T-cell Vaccination

For a T-cell vaccine to be effective, it should be able to induce T-cell cytotoxic and/or regulatory immune responses against the pathogenic T-cells. Studies of T-cell vaccine have indicated that T-cell vaccination with peripheral blood-derived autologous myelin-peptide selected T-cells in multiple sclerosis patients resulted in the in vivo induct
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Opexa Advances Monocyte Derived Islet Technology to Proof of Principle in stz-induced NOD/SCID Mice
2. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
3. Opexa Presents Tovaxin Research at Federation of Clinical Immunology Societies Annual Meeting
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
8. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
9. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
(Date:7/23/2014)... July 23, 2014 The Board of Directors ... leading provider of clinical trial imaging solutions, announced today ... named president and chief executive officer, effective immediately.  Mr. ... 2013 and has held the positions of interim president ... Dr. Charles E. Phelps , Ph.D., chairman ...
(Date:7/23/2014)... , July 23, 2014 Pharmavite LLC ... company,s chief customer officer effective immediately. Toll recently served ... sales and marketing, category management, private label and sales ... In his new global role, Toll will expand his ... sales planning. "Toll,s appointment to chief customer ...
(Date:7/23/2014)... , July 23, 2014  RT Oncology Services Corporation ... to join its board of directors. Mr. Mundie is ... where he works on strategic projects within the company ... Microsoft,s chief research and strategy officer. ... of RainTree, said, "Craig is a visionary technology executive. ...
Breaking Medicine Technology:Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 2Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 3Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 4Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
(Date:7/23/2014)... to better treating the pernicious disorders of obesity and ... from American University,s Center for Behavioral Neuroscience. In the ... therapies aimed at areas of the brain responsible for ... hippocampus could play a role in reducing certain dementias., ... preventive measures often fall short. This is a new ...
(Date:7/23/2014)... Kathleen Doheny ... News) -- Weight-loss surgery appears to have an additional ... in women, according to a new study. The ... weight-loss surgery program reported having incontinence prior to the ... urinary symptoms either improved or disappeared, said study researcher ...
(Date:7/23/2014)... BOSTON In a massive effort to catalog ... researchers at Dana-Farber Cancer Institute, have identified four ... other molecular abnormalities. They say the new classification ... therapies for the third-leading cancer killer worldwide. , ... of The Cancer Genome Atlas Research Network said ...
(Date:7/23/2014)... Arbor, MI (PRWEB) July 23, 2014 ... Real Madrid vs. Manchester United tickets at Michigan Stadium . ... Guinness International Champions Cup will be held at the Big ... University of Michigan Wolverines, will be home to a game ... Madrid from La Liga. The game will be held on ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Ticket Down ... AS Roma tickets in Dallas, TX at the Cotton ... team tournament held in the United States and Canada beginning ... world including teams from La Liga, Serie A, English Premier ... are Manchester United, Manchester City, Olympiacos, Inter Milan, Liverpool, AS ...
Breaking Medicine News(10 mins):Health News:Targeting the brain to treat obesity 2Health News:Targeting the brain to treat obesity 3Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 2Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 3Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3Health News:Real Madrid vs. Manchester United Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for ManU vs. Real Madrid Guinness International Champions Cup Tickets 2Health News:Real Madrid vs. Manchester United Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for ManU vs. Real Madrid Guinness International Champions Cup Tickets 3Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 3
... THERAPIST LEADERS PROVIDE ANALYSIS OF PRESIDENTIAL CANDIDATES,HEALTH CARE ... Americans head,to the polls to cast their votes ... priority; approximately one in three Americans report having,trouble ... crisis and a,shortage of adequate, affordable health insurance ...
... increasingly higher doses of milk over time may ease, ... according to the results of a study led by ... Duke University. , Despite the small number of ... are illuminating and encouraging, investigators say, because this is ...
... Oct. 30 The American Society,for Therapeutic Radiology and ... September 21-25, 2008, at the Boston Convention and,Exhibition Center ... --,a 714 person and 4,900 square feet increase over ... square footage are also,all-time highs for an ASTRO Annual ...
... Services,Inc. (NYSE: AHS ) today announced operating results for the ... million, up 5% over last year and 1% over last quarter ... Revenue growth primarily driven by year-over-year volume increases in ... Locum Tenens. -- EPS of $0.28, up 12% over last ...
... Oct. 30 Kansas State,University and the Kansas ... new venture, "One Health Kansas," will promote,awareness and ... health., The Kansas State University Foundation accepted ... three years for a total of $2,292,308., ...
... 30 Physicians Healthcare,Management Group, Inc. (Phyhealth) (Pink ... in partnership with physicians,today announced that it has ... 30, 2008. The financials are being posted today ... its updated financials, Phyhealth expects to,qualify for the ...
Cached Medicine News:Health News:APTA Podcast Helps Voters Make Informed Decisions on Presidential Candidates' Health Care Plans 2Health News:APTA Podcast Helps Voters Make Informed Decisions on Presidential Candidates' Health Care Plans 3Health News:Drinking milk to ease milk allergy? 2Health News:Drinking milk to ease milk allergy? 3Health News:Premier Radiation Oncology Meeting Breaks Attendance, Exhibit Space Record at Boston Meeting 2Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 2Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 3Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 4Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 5Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 6Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 7Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 8Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 9Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 10Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 11Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 12Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 13Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 14Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 15Health News:K-State and Kansas Health Foundation Team Up to Promote 'One Health Kansas' 2Health News:K-State and Kansas Health Foundation Team Up to Promote 'One Health Kansas' 3Health News:Phyhealth Issues 2008 Third Quarter Financial Statements 2
Fome-Cuf® tubes can breathe with the patient to provide a safe, effective, and low pressure seal throughout the ventilatory cycle....
Portex® pediatric tracheostomy tubes offer a choice in both form and fit. , ,The anatomical shape of the tube shaft along with the caudal angle of the 15 mm connector provide comfort and security...
Indications For Usage: ,Bypass upper airway obstructions, provide long term ventilation, support and/or manage tracheal/bronchial secretions....
KIMBERLY-CLARK BALLARD Neonatal and Pediatric TRACH CARE Manifold features lavage/irrigation port and locking thumb port. Multiple French sizes and packaging configurations. Gamma sterilized....
Medicine Products: